Salmonellosis in children in developing and developed countries and populations

Current Opinion in Infectious Diseases

Volumn 15, Issue 5, 2002, Pages 507-512

  Graham, Stephen M ^a  

^a MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

Author keywords

Antibiotic resistance; Children; Immunization; Salmonella; Typhoid fever

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT INTERLEUKIN 12; TYPHOID VACCINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTHROPATHY; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG INDUCED DISEASE; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENESIS; POPULATION STRUCTURE; REVIEW; SALMONELLA ENTERICA; SALMONELLOSIS; SEROTYPE; TOXICITY; TYPHOID FEVER; CHILD; PATHOPHYSIOLOGY; SALMONELLA TYPHI;

ANTI-BACTERIAL AGENTS; CHILD; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; SALMONELLA INFECTIONS; SALMONELLA TYPHI;

EID: 0036790230     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200210000-00009     Document Type: Review

References (49)

1. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001; 32:263-269.
2. Graham SM, Molyneux EM, Walsh AL, et al. Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J 2000; 19:1189-1196.
3. Sinha A, Sazawal S, Kumar R, et al. Typhoid fever in children aged less than 5 years. Lancet 1999; 354:734-737.
4. Saha SK, Baqui AH, Hanif M, et al. Typhoid fever in Bangladesh: implications for vaccination policy. Pediatr Infect Dis J 2001; 20:521-524.
5. Duggan MB, Beyer L. Enteric fever in young Yoruba children. Arch Dis Child 1975; 50:67-71.
6. Lepage P, Bogaerts J, Van Goethem C, et al. Community-acquired bacteraemia in African children. Lancet 1987; i:1458-1461.
7. Rahman GA, Abubukar AM, Johnson AW, Adeniran JO. Typhoid ileal perforation in Nigerian children: an analysis of 106 operative cases. Pediatr Surg Int 2001; 17:628-630.
8. Walsh AL, Phiri AJ, Graham SM, et al. Bacteremia in febrile Malawian children: clinical and microbiologic features. Pediatr Infect Dis J 2000; 19:312-318.
9. Bahwere P, Levy J, Hennart P, et al. Community-acquired bacteraemia among hospitalized children in rural Central Africa. Int J Infect Dis 2001; 5:180-188.
10. Walsh AL, Molyneux EM, Kabudula M, et al. Bacteraemia following blood transfusion in Malawian children: predominance of Salmonella. Trans R Soc Trop Med Hyg 2002; 96:276-277.
11. Sirinavin S, Chiemchanya S, Vorachit M. Systemic nontyphoidal Salmonella infection in normal infants in Thailand. Pediatr Infect Dis J 2001; 20:581-587.
12. Sahai S, Mahadevan S, Srinivasan S, Kanungo R. Childhood bacterial meningitis in Pondecherry, South India. Indian J Pediatr 2001; 68:839-841.
13. Mahapatra AK, Pawar SJ, Sharma RR. Intracranial Salmonella infections: meningitis, subdural collections and brain abscess. A series of six surgically managed cases with follow-up results. Pediatr Neurosurg 2002; 36:8-13.
14. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002; 360:211-218.
15. Saha MR, Saha D, Dutta P, et al. Isolation of Salmonella enterica serotypes from children with diarrhoea in Calcutta, India. J Health Popul Nutr 2001; 19:301-305.
16. Kafetzis DA, Maltezou HC, Zafeiropoulou A, et al. Epidemiology, clinical course and impact on hospitalization costs of acute diarrhea among hospitalized children in Athens, Greece. Scand J Infect Dis 2001; 33:681-685.
17. Zaidi E, Bachur R, Harper M. Non-typhi Salmonella bacteremia in children. Pediatr Infect Dis J 1999; 18:1073-1077.
18. Bitsori M, Galanakis E, Maraki S, et al. Invasive Salmonella virchow infection in childhood. Scand J Infect Dis 2001; 33:862-865.
19. Arii J, Tanabe Y, Miyake M, et al. Acute encephalopathy associated with nontyphoidal salmonellosis. J Child Neurol 2001; 16:539-540.
20. Rudwaleit M, Richter S, Braun J, Sieper J. Low incidence of reactive arthritis in children following a Salmonella outbreak. Ann Rheum Dis 2001; 60:1055- 1057.
21. Molyneux EM, Walsh A, Phiri A, Molyneux M. Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital, Malawi in 1996-97. Trop Med Int Health 1998; 3:610-618.
22. Gordon MA, Walsh AL, Chaponda M, et al. Bacteraemia and mortality among adult medical admissions in Malawi: predominance of non-typhi Salmonellae and Streptococcus pneumoniae. J Infect 2001; 42:44-49.
23. Amadi B, Kelly P, Mwiya M, et al. Intestinal and systemic infection, HIV, and mortality in Zambian children with persistent diarrhea and malnutrition. J Pediatr Gastroenterol Nutr 2001; 32:550-554.
24. MacLennan C, Lammas D, Casanova J-L, Kumararatne D. Interleukin-12 is a key cytokine which prevents invasive Salmonella sepsis in humans. In: Macrophage Activation and Deactivation: Links between Innate and Acquired Immunity, Abstract 327, p 144, Keystone Symposia; January 22-27 2001; Keystone Symposia, Silverthorne, Colorado, USA. www.keystonesymposia.org
25. Picard C, Fieschi C, Altare F, et al. Inherited interleukin-12 deficiency: IL 12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002; 70:336-348.
26. Perkins DJ, Weinberg JB, Kremsner PG. Reduced interleukin-12 and transforming growth factor-β1 in severe childhood malaria: relationship of cytokine balance with disease severity. J Infect Dis 2000; 182:988-992.
27. Mosser DM, Karp CL. Receptor mediated subversion of macrophage cytokine production by intracellular pathogens. Curr Opin Immunol 1999; 11:406-411.
28. Stevenson MM, Su Z, Sam H, Mohan K. Modulation of host responses to blood-stage malaria by interleukin-12: from therapy to adjuvant activity. Microbes Infect 2001; 3:49-59.
29. Stephens I, Levine MM. Management of typhoid fever in children. Pediatr Infect Dis J 2002; 21:157-158.
30. Gendrel D, Moulin F. Fluoroquinolones in paediatrics. Paediatr Drugs 2001; 3:365-377.
31. Dutta P, Mitra U, Dutta S, et al. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children. Indian J Med Res 2001; 113:210-213.
32. Frenck RW, Nakhla I, Sultan Y, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis 2000; 31:1134-1138.
33. Saha SK, Darmstadt GL, Baqui AH, et al. Rapid identification and antibiotic susceptibility testing of Salmonella enterica serovar Typhi isolated from blood: implications for therapy. J Clin Microbiol 2001; 39:3583-3585.
34. Molbak K, Gerner-Smidt P, Wegener HC. Increasing quinolone resistance in Salmonella enterica serotype Enteritidis. Emerg Infect Dis 2002; 8:514-515.
35. Chiu C-H, Wu T-L, Su L-H, et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N Engl J Med 2002; 346:413-419.
36. Swartz MN. Human diseases caused by foodborne pathogens of animal origin. Clin Infect Dis 2002; 34(suppl 3):S111-S122.
37. Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis 2002; 8:490-495.
38. Travers K, Barza M. Morbidity of infections caused by antimicrobial-resistant bacteria. Clin Infect Dis 2002; 34(suppl 3):S131-S134.
39. Boyd D, Cloeckaert A, Chaslus-Danda E, Mulvey MR. Characterization of variant Salmonella genomic island 1 multidrug resistance regions from serovars Typhimurium DT104 and Agona. Antimicrob Agents Chemother 2002; 46:1714-1722.
40. Swaminathan B, Barrett TJ, Hunter SB, et al. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis 2001; 7:382-389.
41. McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis 2002; 34(suppl 3):S93-S106.
42. Ling ML, Goh KT, Wang GCY, et al. An outbreak of multidrug-resistant Salmonella enterica subs. enterica serotype Typhimurium, DT104L linked to dried anchovy in Singapore. Epidemiol Infect 2002; 128:1-5.
43. Gasem MH, Dolmans WM, Keuter MM, Djokomoeljanto RR. Poor food hygiene and housing as risk factors for typhoid fever in Semarang, Indonesia. Trop Med Int Health 2001; 6:484-490.
44. Mermin JH, Villar R, Carpenter J, et al. A massive epidemic of multi-drugresistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis 1999; 179:1416-1422.
45. Lin FYC, Ho VA, Kheim HB, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001; 344:1263-1269.
46. Yang HH, Kilgore PE, Yang LH, et al. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine. J Infect Dis 2001; 183:1775-1780.
47. House JK, Ontiveros MM, Blackmer NM, et al. Evaluation of an autogenous Salmonella bacterin and a modified live Salmonella serotype Choleraesuis vaccine on a commercial dairy farm. Am J Vet Res 2001; 62:1897-1902.
48. Feberwee A, de Vries TS, Hartman EG, et al. Vaccination against Salmonella enteritidis in Dutch commercial layer flocks with a vaccine based on a live Salmonella gallinarum 9R strain: evaluation of efficacy, safety, and performance of serologic Salmonella tests. Avian Dis 2001; 45:83-91.
49. Takehara K, Kikuma R, Ishikawa S, et al. Production and in vivo testing of a recombinant bovine IL-12 as an adjuvant for Salmonella Typhimurium vaccination in calves. Vet Immunol Immunopathol 2002; 86:23-30.